Flotufolastat F-18 Gallium Patent Expiration
Flotufolastat F-18 Gallium is used for imaging prostate cancer recurrence. It was first introduced by Blue Earth Diagnostics Ltd
Flotufolastat F-18 Gallium Patents
Given below is the list of patents protecting Flotufolastat F-18 Gallium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Posluma | US11413360 | Dual mode radiotracer and—therapeutics | Nov 22, 2038 | Blue Earth |